Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Vaccine no replacement for Pap test

The Cancer Council Australia cautioned that the vaccine was not a substitute for the Pap screen and that all women aged 18-69 should continue regular two year screening.

27 Jun 2006

New push to tackle priorities in sexual and reproductive health

Leaders of the World Health Organization (WHO) and UNFPA, the United Nations Population Fund, are coordinating action to reverse the global trend of deteriorating levels of sexual and reproductive health and reduce the adverse impact on mothers, babies and young people.

20 Jun 2006

First drug treatment for late-stage cervical cancer approved

FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.

18 Jun 2006

FDA approves cervical cancer vaccine

The Federal Drug Administration (FDA) in the U.S. has recently given its approval for a new vaccine which protects against the human papillomavirus known as HPV.

12 Jun 2006

PATH to pave the way for cervical cancer vaccines in the developing world

The global health nonprofit PATH has launched a five-year effort to make sure that new cervical cancer vaccines - the first vaccines developed and approved just for women's health - reach women in the developing world.

9 Jun 2006

How cow warts, clergy sex surveys moved along cervical cancer vaccine

The creation of a successful vaccine against cervical cancer, approved today by the U.S. Food and Drug Administration, is the culmination of research that occurred thanks not only to scientists and physicians, but also to generous farmers and veterinarians, priests and nuns willing to tell all - and some very patient cows.

9 Jun 2006

New era in cancer prevention

Nearly two decades ago, researchers at the National Cancer Institute (NCI) and other institutions began searching for the underlying causes of cervical cancer.

9 Jun 2006

FDA approves Gardasil as a treatment for cervical cancer

Merck & Co. has announced that the U.S. Food and Drug Administration (FDA) approved Gardasil as a treatment for cervical cancer, vulvar and vaginal pre-cancers caused by HPV types 16 and 18 and to prevent low-grade and pre-cancerous lesions and genital warts caused by HPV types 6, 11, 16 and 18.

9 Jun 2006

FDA approval of Gardasil to prevent cervical cancer

The Food and Drug Administration (FDA) has announced the approval of Gardasil, the first vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to human papillomavirus (HPV) types 6, 11, 16 and 18.

8 Jun 2006

Human Papillomavirus testing and liquid-based cytology

Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions of the cervix, a study in the Journal of the National Cancer Institute reports.

7 Jun 2006

Bill Gates puts his money where his mouth is again

Once again Microsoft founder Bill Gates is putting his money where his mouth is and the world's poorest women will benefit.

6 Jun 2006

New cervical cancer vaccine offers women 100% protection

Although there have been significant advancements in the screening and treatment of cancer, thousands of women every year contract cervical cancer.

6 Jun 2006

Vaccine against cervical cancer on track for FDA approval

According to the Food and Drug Administration in the U.S. an experimental vaccine which prevents cervical cancer appears to be effective and has no major safety concerns.

17 May 2006

An engineered virus that tracks down and compels cancer cells to eat themselves

An engineered virus tracks down and infects the most common and deadly form of brain cancer and then kills tumor cells by forcing them to devour themselves, researchers at The University of Texas M. D. Anderson Cancer Center report.

3 May 2006

Combo of testing and vaccines a winner in fight against cervical cancer

According to experts in reproductive health, the combination of HPV testing with HPV vaccines is the best hope for preventing cervical cancer.

1 May 2006

Cervical cancer vaccine gives women 4 years protection

Researchers say a vaccine that protects women against a virus that causes cervical cancer is effective for more than four years.

6 Apr 2006

High glucose-uptake tumors can be identified with PET scans

Cervical cancers that take up a lot of blood sugar, or glucose, are more resistant to treatment than those that are less glucose-hungry, according to research at Washington University School of Medicine in St. Louis.

4 Apr 2006

Studies show HPV testing is more sensitive than current screening methods

The current technique for screening for cervical cancer involves collecting cells by way of a pap smear and examining them under a microscope. Although this method has reduced cervical cancer in countries where it is regularly used, it has several weaknesses.

3 Apr 2006

HPV vaccines provide hope for major international programmes of primary prevention

Parents of young girls may soon be offered the opportunity to have their daughters immunised against a sexually transmitted virus that is the major cause of cervical cancer, the 4th International Conference on Teenage and Young Adult Cancer Medicine.

3 Apr 2006

Human papillomavirus infections and incidence of squamous cell and basal cell carcinomas of the skin

Infection with human papillomavirus (HPV) types called beta HPVs may be associated with an increased risk of developing a major type of skin cancer known as squamous cell carcinoma (SCC)

15 Mar 2006